Sacral Neuromodulation with the InterStim™ System for Intractable Lower Urinary Tract Dysfunctions (SOUNDS): Results of Clinical Effectiveness, Quality of Life, Patient-Reported Outcomes and Safety in a French Multicenter Observational Study.

[1]  L. Souter,et al.  Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019. , 2019, The Journal of urology.

[2]  K. Matzel,et al.  Sacral Neuromodulation: Standardized Electrode Placement Technique , 2017, Neuromodulation : journal of the International Neuromodulation Society.

[3]  Jeffrey A. Johnson,et al.  Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores. , 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[4]  K. Kreder,et al.  Detailed analysis of adverse events and surgical interventions in a large prospective trial of sacral neuromodulation therapy for overactive bladder patients , 2017, Neurourology and urodynamics.

[5]  H. Zyczynski,et al.  OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial. , 2016, JAMA.

[6]  C. Comiter,et al.  Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder , 2016, Neurourology and urodynamics.

[7]  T. Alexander,et al.  The psychological impact of overactive bladder: A systematic review , 2016, Journal of health psychology.

[8]  M. Faraday,et al.  Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. , 2015, The Journal of urology.

[9]  A. Wailoo,et al.  A review of the psychometric performance of the EQ-5D in people with urinary incontinence , 2013, Health and Quality of Life Outcomes.

[10]  G. Bonsel,et al.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) , 2011, Quality of Life Research.

[11]  X. Gamé,et al.  Neuromodulation sacrée avec le système InterStim™ : résultats du registre national français , 2011 .

[12]  Jennifer M Wu,et al.  Efficacy and adverse events of sacral nerve stimulation for overactive bladder: A systematic review , 2010, Neurourology and urodynamics.

[13]  G. Amarenco,et al.  Comprehensive evaluation of bladder and urethral dysfunction symptoms: development and psychometric validation of the Urinary Symptom Profile (USP) questionnaire. , 2008, Urology.

[14]  A. Garratt,et al.  EuroQol EQ-5D and condition-specific measures of health outcome in women with urinary incontinence: reliability, validity and responsiveness , 2008, Quality of Life Research.

[15]  M. Elhilali,et al.  Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. , 2007, The Journal of urology.

[16]  K. Coyne,et al.  Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. , 2006, European urology.

[17]  C. Kelleher,et al.  The current and future burden and cost of overactive bladder in five European countries. , 2006, European urology.

[18]  P. Abrams,et al.  Impact of overactive bladder symptoms on employment, social interactions and emotional well‐being in six European countries , 2006, BJU international.

[19]  T. Wagner,et al.  Health‐related consequences of overactive bladder: an economic perspective , 2005, BJU international.

[20]  M. Nichol,et al.  Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the california medicaid program. , 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[21]  B. Schurch,et al.  Buttock Placement of the Implantable Pulse Generator: A New Implantation Technique for Sacral Neuromodulation – A Multicenter Study , 2001, European Urology.

[22]  M. Spinelli,et al.  Chronic sacral neuromodulation in patients with lower urinary tract symptoms: results from a national register. , 2001, The Journal of urology.

[23]  P. Abrams,et al.  How widespread are the symptoms of an overactive bladder and how are they managed? A population‐based prevalence study , 2001, BJU international.

[24]  M. Elhilali,et al.  Sacral neuromodulation in the treatment of urgency-frequency symptoms: a multicenter study on efficacy and safety. , 2000, The Journal of urology.

[25]  G. King,et al.  Goal Attainment Scaling , 2000 .

[26]  Richard A. Schmidt,et al.  SACRAL NERVE STIMULATION FOR TREATMENT OF REFRACTORY URINARY URGE INCONTINENCE , 1999 .

[27]  G. Amarenco,et al.  Une échelle spécifique d'évaluation de la perturbation de la qualité de vie au cours des troubles mictionnels: l'échelle Ditrovie , 1997 .

[28]  S. Wexner,et al.  Etiology and management of fecal incontinence , 1993, Diseases of the colon and rectum.